Global Pharmatech GBLP Stock
Global Pharmatech Price Chart
Global Pharmatech GBLP Financial and Trading Overview
| Global Pharmatech stock price | 0.2 USD |
| Previous Close | 0.12 USD |
| Open | 0.12 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.12 - 0.12 USD |
| 52 Week Range | 0.11 - 0.2 USD |
| Volume | 208 USD |
| Avg. Volume | 116 USD |
| Market Cap | 1.42M USD |
| Beta (5Y Monthly) | -2.697183 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GBLP Valuation Measures
| Enterprise Value | 1.23M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.44561598 |
| Price/Book (mrq) | 0.34985423 |
| Enterprise Value/Revenue | 0.388 |
| Enterprise Value/EBITDA | -0.68 |
Trading Information
Global Pharmatech Stock Price History
| Beta (5Y Monthly) | -2.697183 |
| 52-Week Change | -19.99% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.2 USD |
| 52 Week Low | 0.11 USD |
| 50-Day Moving Average | 0.16 USD |
| 200-Day Moving Average | 0.19 USD |
GBLP Share Statistics
| Avg. Volume (3 month) | 116 USD |
| Avg. Daily Volume (10-Days) | 20 USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2007 |
| Most Recent Quarter (mrq) | June 30, 2008 |
| Next Fiscal Year End | December 31, 2008 |
Profitability
| Profit Margin | -70.45% |
| Operating Margin (ttm) | -72.54% |
| Gross Margin | 46.24% |
| EBITDA Margin | -57.033% |
Management Effectiveness
| Return on Assets (ttm) | -10.39% |
| Return on Equity (ttm) | -22.58% |
Income Statement
| Revenue (ttm) | 3.18M USD |
| Revenue Per Share (ttm) | 0.14 USD |
| Quarterly Revenue Growth (yoy) | 21.50% |
| Gross Profit (ttm) | 1.32M USD |
| EBITDA | -1813375 USD |
| Net Income Avi to Common (ttm) | -2240033 USD |
| Diluted EPS (ttm) | -0.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.44M USD |
| Total Cash Per Share (mrq) | 0.23 USD |
| Total Debt (mrq) | 2.62M USD |
| Total Debt/Equity (mrq) | 28.58 USD |
| Current Ratio (mrq) | 1.858 |
| Book Value Per Share (mrq) | 0.343 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 170.85K USD |
| Levered Free Cash Flow (ttm) | 325.78K USD |
Profile of Global Pharmatech
| Country | United States |
| State | N/A |
| City | Changchun |
| Address | 509 Maoxiang Street |
| ZIP | 130 012 |
| Phone | 86 431 8554 1826 |
| Website | N/A |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 217 |
Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.
Q&A For Global Pharmatech Stock
What is a current GBLP stock price?
Global Pharmatech GBLP stock price today per share is 0.2 USD.
How to purchase Global Pharmatech stock?
You can buy GBLP shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Global Pharmatech?
The stock symbol or ticker of Global Pharmatech is GBLP.
Which industry does the Global Pharmatech company belong to?
The Global Pharmatech industry is Drug Manufacturers-Specialty & Generic.
How many shares does Global Pharmatech have in circulation?
The max supply of Global Pharmatech shares is 415.21M.
What is Global Pharmatech Price to Earnings Ratio (PE Ratio)?
Global Pharmatech PE Ratio is now.
What was Global Pharmatech earnings per share over the trailing 12 months (TTM)?
Global Pharmatech EPS is -0.3 USD over the trailing 12 months.
Which sector does the Global Pharmatech company belong to?
The Global Pharmatech sector is Healthcare.